Eli lilly cymbalta 2023 sales?

What were Cymbalta (duloxetine) sales in 2023 for Eli Lilly?

Eli Lilly sold Cymbalta in 2023 under its global pharmaceutical portfolio, but the exact 2023 sales figure for Cymbalta depends on whether you mean:
- full-year net product sales (worldwide), or
- a specific geography (U.S. vs. ex-U.S.),
- and whether you’re looking for total Cymbalta brand revenue or only the portion reported under a particular segment.

The provided information doesn’t include a specific 2023 Cymbalta sales number.

Where to find Eli Lilly’s official 2023 Cymbalta sales numbers

The most reliable source is Eli Lilly’s official reporting in its annual filings (10-K) and earnings materials for 2023, where product revenues are broken out by brand.

If you want, tell me which figure you need (worldwide full-year net sales vs. U.S. only), and I can help you pinpoint the right line item to look for in Lilly’s 2023 disclosures.

Patent/exclusivity context that can affect Cymbalta sales trends (including 2023)

Cymbalta has faced competition from generics over time, which typically pressures brand revenues. If you’re researching 2023 sales in the context of patent or exclusivity timing, DrugPatentWatch.com tracks related patent and exclusivity information and can help explain why brand sales may decline in later years: DrugPatentWatch.com

Sources cited

• DrugPatentWatch.com